Audit Response_Obs_Minor 2A_Safety goggle_2024
Audit Response_Obs_Minor 2A_Safety goggle_2024
Audit Response_Obs_Minor 2A_Safety goggle_2024
No
Yes, Reference Audit / Observation:
(6) Does the observation meet the definition of a non-conformance? If yes, enter the Record ID number initiated for
the observation.
No (Proceed to Step 7)
Yes, Reference Record ID #(s): (Skip Steps 7 & 8)
Screening study of Leachables are usually performed as fit to purpose approach as a method verification. Method
verification is performed to prove method suitability as to screen the Leachables in drug product, by establishing
system suitability & spike sample through class-B study protocol. As solution stability is not established for same,
Solutions were marked as TBD as per SOP BXU572902 Handling of reconstituted solutions.
We acknowledge that Protocol number was missed from Page-2 in BXU610499 Study for Screening of Organic
Leachables in Diazepam Injection USP, 5 mg/mL.
Impact assessment:
Method suitability (on time use method suitability) is established by precision and sensitivity at Target specific
AET/reporting threshold level. These solutions are not evaluated for solution stability due to nature and objective of
method. In case of use beyond 24 hrs due to longer sequences or any other challenges, system suitability solutions
are used till data meets the acceptance criteria. Any degradation of due to aging, will produce a worst case scenario
in terms of sensitivity and precision in System suitability and leachable sample evaluation. Further, appropriate
system suitability including bracketing standard is also being evaluated after samples analysis. There is no impact as
PARENT DOCUMENT(S): GQP-02-01 Page 1 of 4 FORM NO.: GQF-02-01-02
(current rev.) CHANGE NO.: C
BAXTER CONFIDENTIAL – INTERNAL USE ONLY ISSUE DATE: 23-Feb-2022
EFFECTIVE DATE: 25-Mar-2022
(1) Auditing Group (Name): Local Internal Audit Audit Number (as provided by Audit Group): 540769 Observation Number(s) (which are addressed): 04 (e)
APPROVAL
(Print Name / Sign / Date)
(9) Prepared by: (person who prepared Part1 of observation record)
(Print Name / Sign / Date)
(10) Observation Owner:
(11) Quality Representative: (If the Observation owner is Quality (Print Name / Sign / Date)
Representative, this rationale can be entered, and approval may be waived.)
Accept
Reject, Rationale for Rejection:
ACTION IMPLEMENTATION
(15) Date all actions have been completed:
(16) Objective Evidence of Implementation and Effectiveness:
Attach or reference the supporting documentation:
VERIFICATION
(Print Name / Sign / Date)
(17) Prepared by:
(Print Name / Sign / Date)
(18) Observation Owner:
(19) Quality Representative: (If the Observation owner is Quality (Print Name / Sign / Date)
Representative, this rationale can be entered and approval may be waived.)
(20) Disposition